Eisai's reports dosing of antibody therapy E2814 in phase 2/3 Alzheimer's disease trial
January 19 2022 - 8:54AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Eisai (PK) (USOTC:ESALY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Eisai (PK) (USOTC:ESALY)
Historical Stock Chart
From Apr 2023 to Apr 2024